| dc.contributor.author |
Gedefa, Bikila |
|
| dc.date.accessioned |
2025-03-26T08:31:48Z |
|
| dc.date.available |
2025-03-26T08:31:48Z |
|
| dc.date.issued |
44531 |
|
| dc.identifier.citation |
Submitted by iphce iphce (iphce-e@gmail.com) on 2025-03-26T08:31:48Z
No. of bitstreams: 0 |
en_US |
| dc.identifier.citation |
Made available in DSpace on 2025-03-26T08:31:48Z (GMT). No. of bitstreams: 0
Previous issue date: 2021-12 |
en_US |
| dc.description.abstract |
Neurocognitive disorders in patients with type 2 Diabetes Mellitus has spectrum
manifestation which might range from subtle executive dysfunction to memory loss and overt
dementia. Diabetes patients are at higher risk of all types of cognitive impairment, mainly
because some diabetes complications results in cognitive impairments and they are also being
considered as disease of the same spectrum. Even though it is estimated that more than 50
million peoples live with dementia worldwide, there is no enough data from low and middle
income countries, including Ethiopia, where the number is projected to increase to 152 million
by 2050. Hence this study will focus on assessing the overall prevalence, potential determinant
and contributing factors among patients with type 2 DM over a period of two months at Black
Lion Specialized Hospital, Ethiopia. |
en_US |
| dc.language.iso |
https://etd.aau.edu.et/items/e10dc653-dce1-4060-8745-3e2e9eda18d7 |
|
| dc.language.iso |
en |
en_US |
| dc.subject |
Diabetes |
|
| dc.title.alternative |
Prevalence of Neurocognitive Impairment and Associated Factors among Type-2 Diabetic Patients on Follow Up at Diabetic Clinic, Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia |
en_US |
| dc.type |
Thesis |
S |